Global Prescription Dermatological Drugs Market Growth 2023-2028

Report ID: 1210459 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Prescription Dermatological Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Prescription Dermatological Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Prescription Dermatological Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Prescription Dermatological Drugs Segment by Type
        2.2.1 Anti-acne Drugs
        2.2.2 Anti-aging Drugs
        2.2.3 Dermatitis Drugs
        2.2.4 Hair Loss Drugs
        2.2.5 Psoriasis Drugs
        2.2.6 Skin Cancer Drugs
        2.2.7 Melasma Drugs
        2.2.8 Seborrhea Drugs
    2.3 Prescription Dermatological Drugs Sales by Type
        2.3.1 Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Prescription Dermatological Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Prescription Dermatological Drugs Sale Price by Type (2017-2022)
    2.4 Prescription Dermatological Drugs Segment by Application
        2.4.1 Hospital Pharmacies
        2.4.2 Retail Pharmacies
        2.4.3 Online Pharmacies
    2.5 Prescription Dermatological Drugs Sales by Application
        2.5.1 Global Prescription Dermatological Drugs Sale Market Share by Application (2017-2022)
        2.5.2 Global Prescription Dermatological Drugs Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Prescription Dermatological Drugs Sale Price by Application (2017-2022)
3 Global Prescription Dermatological Drugs by Company
    3.1 Global Prescription Dermatological Drugs Breakdown Data by Company
        3.1.1 Global Prescription Dermatological Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Prescription Dermatological Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Prescription Dermatological Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Prescription Dermatological Drugs Revenue by Company (2020-2022)
        3.2.2 Global Prescription Dermatological Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Prescription Dermatological Drugs Sale Price by Company
    3.4 Key Manufacturers Prescription Dermatological Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Prescription Dermatological Drugs Product Location Distribution
        3.4.2 Players Prescription Dermatological Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prescription Dermatological Drugs by Geographic Region
    4.1 World Historic Prescription Dermatological Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Prescription Dermatological Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Prescription Dermatological Drugs Annual Revenue by Geographic Region
    4.2 World Historic Prescription Dermatological Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Prescription Dermatological Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Prescription Dermatological Drugs Annual Revenue by Country/Region
    4.3 Americas Prescription Dermatological Drugs Sales Growth
    4.4 APAC Prescription Dermatological Drugs Sales Growth
    4.5 Europe Prescription Dermatological Drugs Sales Growth
    4.6 Middle East & Africa Prescription Dermatological Drugs Sales Growth
5 Americas
    5.1 Americas Prescription Dermatological Drugs Sales by Country
        5.1.1 Americas Prescription Dermatological Drugs Sales by Country (2017-2022)
        5.1.2 Americas Prescription Dermatological Drugs Revenue by Country (2017-2022)
    5.2 Americas Prescription Dermatological Drugs Sales by Type
    5.3 Americas Prescription Dermatological Drugs Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Prescription Dermatological Drugs Sales by Region
        6.1.1 APAC Prescription Dermatological Drugs Sales by Region (2017-2022)
        6.1.2 APAC Prescription Dermatological Drugs Revenue by Region (2017-2022)
    6.2 APAC Prescription Dermatological Drugs Sales by Type
    6.3 APAC Prescription Dermatological Drugs Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Prescription Dermatological Drugs by Country
        7.1.1 Europe Prescription Dermatological Drugs Sales by Country (2017-2022)
        7.1.2 Europe Prescription Dermatological Drugs Revenue by Country (2017-2022)
    7.2 Europe Prescription Dermatological Drugs Sales by Type
    7.3 Europe Prescription Dermatological Drugs Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Prescription Dermatological Drugs by Country
        8.1.1 Middle East & Africa Prescription Dermatological Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Prescription Dermatological Drugs Sales by Type
    8.3 Middle East & Africa Prescription Dermatological Drugs Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Prescription Dermatological Drugs
    10.3 Manufacturing Process Analysis of Prescription Dermatological Drugs
    10.4 Industry Chain Structure of Prescription Dermatological Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Prescription Dermatological Drugs Distributors
    11.3 Prescription Dermatological Drugs Customer
12 World Forecast Review for Prescription Dermatological Drugs by Geographic Region
    12.1 Global Prescription Dermatological Drugs Market Size Forecast by Region
        12.1.1 Global Prescription Dermatological Drugs Forecast by Region (2023-2028)
        12.1.2 Global Prescription Dermatological Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Prescription Dermatological Drugs Forecast by Type
    12.7 Global Prescription Dermatological Drugs Forecast by Application
13 Key Players Analysis
    13.1 Johnson & Johnson
        13.1.1 Johnson & Johnson Company Information
        13.1.2 Johnson & Johnson Prescription Dermatological Drugs Product Offered
        13.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Johnson & Johnson Main Business Overview
        13.1.5 Johnson & Johnson Latest Developments
    13.2 Merck
        13.2.1 Merck Company Information
        13.2.2 Merck Prescription Dermatological Drugs Product Offered
        13.2.3 Merck Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Merck Main Business Overview
        13.2.5 Merck Latest Developments
    13.3 LEO Pharma
        13.3.1 LEO Pharma Company Information
        13.3.2 LEO Pharma Prescription Dermatological Drugs Product Offered
        13.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 LEO Pharma Main Business Overview
        13.3.5 LEO Pharma Latest Developments
    13.4 Mylan Pharmaceuticals
        13.4.1 Mylan Pharmaceuticals Company Information
        13.4.2 Mylan Pharmaceuticals Prescription Dermatological Drugs Product Offered
        13.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Mylan Pharmaceuticals Main Business Overview
        13.4.5 Mylan Pharmaceuticals Latest Developments
    13.5 Pfizer
        13.5.1 Pfizer Company Information
        13.5.2 Pfizer Prescription Dermatological Drugs Product Offered
        13.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Pfizer Main Business Overview
        13.5.5 Pfizer Latest Developments
    13.6 Roche
        13.6.1 Roche Company Information
        13.6.2 Roche Prescription Dermatological Drugs Product Offered
        13.6.3 Roche Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Roche Main Business Overview
        13.6.5 Roche Latest Developments
    13.7 Allergan
        13.7.1 Allergan Company Information
        13.7.2 Allergan Prescription Dermatological Drugs Product Offered
        13.7.3 Allergan Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Allergan Main Business Overview
        13.7.5 Allergan Latest Developments
    13.8 Bausch Health
        13.8.1 Bausch Health Company Information
        13.8.2 Bausch Health Prescription Dermatological Drugs Product Offered
        13.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Bausch Health Main Business Overview
        13.8.5 Bausch Health Latest Developments
    13.9 PharmaDerm Pharmaceuticals
        13.9.1 PharmaDerm Pharmaceuticals Company Information
        13.9.2 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Offered
        13.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 PharmaDerm Pharmaceuticals Main Business Overview
        13.9.5 PharmaDerm Pharmaceuticals Latest Developments
    13.10 Allergan Inamed Corporation
        13.10.1 Allergan Inamed Corporation Company Information
        13.10.2 Allergan Inamed Corporation Prescription Dermatological Drugs Product Offered
        13.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Allergan Inamed Corporation Main Business Overview
        13.10.5 Allergan Inamed Corporation Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Prescription Dermatological Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Prescription Dermatological Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Anti-acne Drugs
    Table 4. Major Players of Anti-aging Drugs
    Table 5. Major Players of Dermatitis Drugs
    Table 6. Major Players of Hair Loss Drugs
    Table 7. Major Players of Psoriasis Drugs
    Table 8. Major Players of Skin Cancer Drugs
    Table 9. Major Players of Melasma Drugs
    Table 10. Major Players of Seborrhea Drugs
    Table 11. Global Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
    Table 12. Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)
    Table 13. Global Prescription Dermatological Drugs Revenue by Type (2017-2022) & ($ million)
    Table 14. Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2022)
    Table 15. Global Prescription Dermatological Drugs Sale Price by Type (2017-2022) & (USD/Units)
    Table 16. Global Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
    Table 17. Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)
    Table 18. Global Prescription Dermatological Drugs Revenue by Application (2017-2022)
    Table 19. Global Prescription Dermatological Drugs Revenue Market Share by Application (2017-2022)
    Table 20. Global Prescription Dermatological Drugs Sale Price by Application (2017-2022) & (USD/Units)
    Table 21. Global Prescription Dermatological Drugs Sales by Company (2020-2022) & (K Units)
    Table 22. Global Prescription Dermatological Drugs Sales Market Share by Company (2020-2022)
    Table 23. Global Prescription Dermatological Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 24. Global Prescription Dermatological Drugs Revenue Market Share by Company (2020-2022)
    Table 25. Global Prescription Dermatological Drugs Sale Price by Company (2020-2022) & (USD/Units)
    Table 26. Key Manufacturers Prescription Dermatological Drugs Producing Area Distribution and Sales Area
    Table 27. Players Prescription Dermatological Drugs Products Offered
    Table 28. Prescription Dermatological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 29. New Products and Potential Entrants
    Table 30. Mergers & Acquisitions, Expansion
    Table 31. Global Prescription Dermatological Drugs Sales by Geographic Region (2017-2022) & (K Units)
    Table 32. Global Prescription Dermatological Drugs Sales Market Share Geographic Region (2017-2022)
    Table 33. Global Prescription Dermatological Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 34. Global Prescription Dermatological Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 35. Global Prescription Dermatological Drugs Sales by Country/Region (2017-2022) & (K Units)
    Table 36. Global Prescription Dermatological Drugs Sales Market Share by Country/Region (2017-2022)
    Table 37. Global Prescription Dermatological Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 38. Global Prescription Dermatological Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 39. Americas Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
    Table 40. Americas Prescription Dermatological Drugs Sales Market Share by Country (2017-2022)
    Table 41. Americas Prescription Dermatological Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 42. Americas Prescription Dermatological Drugs Revenue Market Share by Country (2017-2022)
    Table 43. Americas Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
    Table 44. Americas Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)
    Table 45. Americas Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
    Table 46. Americas Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)
    Table 47. APAC Prescription Dermatological Drugs Sales by Region (2017-2022) & (K Units)
    Table 48. APAC Prescription Dermatological Drugs Sales Market Share by Region (2017-2022)
    Table 49. APAC Prescription Dermatological Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 50. APAC Prescription Dermatological Drugs Revenue Market Share by Region (2017-2022)
    Table 51. APAC Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
    Table 52. APAC Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)
    Table 53. APAC Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
    Table 54. APAC Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)
    Table 55. Europe Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
    Table 56. Europe Prescription Dermatological Drugs Sales Market Share by Country (2017-2022)
    Table 57. Europe Prescription Dermatological Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 58. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2017-2022)
    Table 59. Europe Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)
    Table 61. Europe Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)
    Table 63. Middle East & Africa Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
    Table 64. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Country (2017-2022)
    Table 65. Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 66. Middle East & Africa Prescription Dermatological Drugs Revenue Market Share by Country (2017-2022)
    Table 67. Middle East & Africa Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
    Table 68. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)
    Table 69. Middle East & Africa Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
    Table 70. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)
    Table 71. Key Market Drivers & Growth Opportunities of Prescription Dermatological Drugs
    Table 72. Key Market Challenges & Risks of Prescription Dermatological Drugs
    Table 73. Key Industry Trends of Prescription Dermatological Drugs
    Table 74. Prescription Dermatological Drugs Raw Material
    Table 75. Key Suppliers of Raw Materials
    Table 76. Prescription Dermatological Drugs Distributors List
    Table 77. Prescription Dermatological Drugs Customer List
    Table 78. Global Prescription Dermatological Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. Global Prescription Dermatological Drugs Sales Market Forecast by Region
    Table 80. Global Prescription Dermatological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 82. Americas Prescription Dermatological Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Americas Prescription Dermatological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. APAC Prescription Dermatological Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 85. APAC Prescription Dermatological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 86. Europe Prescription Dermatological Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 87. Europe Prescription Dermatological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 88. Middle East & Africa Prescription Dermatological Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 89. Middle East & Africa Prescription Dermatological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 90. Global Prescription Dermatological Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 91. Global Prescription Dermatological Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 92. Global Prescription Dermatological Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 93. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 94. Global Prescription Dermatological Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 95. Global Prescription Dermatological Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 96. Global Prescription Dermatological Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 97. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 98. Johnson & Johnson Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 99. Johnson & Johnson Prescription Dermatological Drugs Product Offered
    Table 100. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 101. Johnson & Johnson Main Business
    Table 102. Johnson & Johnson Latest Developments
    Table 103. Merck Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 104. Merck Prescription Dermatological Drugs Product Offered
    Table 105. Merck Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 106. Merck Main Business
    Table 107. Merck Latest Developments
    Table 108. LEO Pharma Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 109. LEO Pharma Prescription Dermatological Drugs Product Offered
    Table 110. LEO Pharma Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 111. LEO Pharma Main Business
    Table 112. LEO Pharma Latest Developments
    Table 113. Mylan Pharmaceuticals Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 114. Mylan Pharmaceuticals Prescription Dermatological Drugs Product Offered
    Table 115. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 116. Mylan Pharmaceuticals Main Business
    Table 117. Mylan Pharmaceuticals Latest Developments
    Table 118. Pfizer Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 119. Pfizer Prescription Dermatological Drugs Product Offered
    Table 120. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 121. Pfizer Main Business
    Table 122. Pfizer Latest Developments
    Table 123. Roche Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 124. Roche Prescription Dermatological Drugs Product Offered
    Table 125. Roche Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 126. Roche Main Business
    Table 127. Roche Latest Developments
    Table 128. Allergan Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 129. Allergan Prescription Dermatological Drugs Product Offered
    Table 130. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 131. Allergan Main Business
    Table 132. Allergan Latest Developments
    Table 133. Bausch Health Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 134. Bausch Health Prescription Dermatological Drugs Product Offered
    Table 135. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 136. Bausch Health Main Business
    Table 137. Bausch Health Latest Developments
    Table 138. PharmaDerm Pharmaceuticals Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 139. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Offered
    Table 140. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 141. PharmaDerm Pharmaceuticals Main Business
    Table 142. PharmaDerm Pharmaceuticals Latest Developments
    Table 143. Allergan Inamed Corporation Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 144. Allergan Inamed Corporation Prescription Dermatological Drugs Product Offered
    Table 145. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)
    Table 146. Allergan Inamed Corporation Main Business
    Table 147. Allergan Inamed Corporation Latest Developments
List of Figures
    Figure 1. Picture of Prescription Dermatological Drugs
    Figure 2. Prescription Dermatological Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Prescription Dermatological Drugs Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Prescription Dermatological Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Prescription Dermatological Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Anti-acne Drugs
    Figure 10. Product Picture of Anti-aging Drugs
    Figure 11. Product Picture of Dermatitis Drugs
    Figure 12. Product Picture of Hair Loss Drugs
    Figure 13. Product Picture of Psoriasis Drugs
    Figure 14. Product Picture of Skin Cancer Drugs
    Figure 15. Product Picture of Melasma Drugs
    Figure 16. Product Picture of Seborrhea Drugs
    Figure 17. Global Prescription Dermatological Drugs Sales Market Share by Type in 2021
    Figure 18. Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2022)
    Figure 19. Prescription Dermatological Drugs Consumed in Hospital Pharmacies
    Figure 20. Global Prescription Dermatological Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)
    Figure 21. Prescription Dermatological Drugs Consumed in Retail Pharmacies
    Figure 22. Global Prescription Dermatological Drugs Market: Retail Pharmacies (2017-2022) & (K Units)
    Figure 23. Prescription Dermatological Drugs Consumed in Online Pharmacies
    Figure 24. Global Prescription Dermatological Drugs Market: Online Pharmacies (2017-2022) & (K Units)
    Figure 25. Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)
    Figure 26. Global Prescription Dermatological Drugs Revenue Market Share by Application in 2021
    Figure 27. Prescription Dermatological Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 28. Global Prescription Dermatological Drugs Revenue Market Share by Company in 2021
    Figure 29. Global Prescription Dermatological Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 30. Global Prescription Dermatological Drugs Revenue Market Share by Geographic Region in 2021
    Figure 31. Global Prescription Dermatological Drugs Sales Market Share by Region (2017-2022)
    Figure 32. Global Prescription Dermatological Drugs Revenue Market Share by Country/Region in 2021
    Figure 33. Americas Prescription Dermatological Drugs Sales 2017-2022 (K Units)
    Figure 34. Americas Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)
    Figure 35. APAC Prescription Dermatological Drugs Sales 2017-2022 (K Units)
    Figure 36. APAC Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)
    Figure 37. Europe Prescription Dermatological Drugs Sales 2017-2022 (K Units)
    Figure 38. Europe Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)
    Figure 39. Middle East & Africa Prescription Dermatological Drugs Sales 2017-2022 (K Units)
    Figure 40. Middle East & Africa Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)
    Figure 41. Americas Prescription Dermatological Drugs Sales Market Share by Country in 2021
    Figure 42. Americas Prescription Dermatological Drugs Revenue Market Share by Country in 2021
    Figure 43. United States Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Canada Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Mexico Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Brazil Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 47. APAC Prescription Dermatological Drugs Sales Market Share by Region in 2021
    Figure 48. APAC Prescription Dermatological Drugs Revenue Market Share by Regions in 2021
    Figure 49. China Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Japan Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 51. South Korea Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Southeast Asia Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 53. India Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Australia Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Europe Prescription Dermatological Drugs Sales Market Share by Country in 2021
    Figure 56. Europe Prescription Dermatological Drugs Revenue Market Share by Country in 2021
    Figure 57. Germany Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 58. France Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 59. UK Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Italy Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Russia Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Country in 2021
    Figure 63. Middle East & Africa Prescription Dermatological Drugs Revenue Market Share by Country in 2021
    Figure 64. Egypt Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 65. South Africa Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Israel Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Turkey Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 68. GCC Country Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 69. Manufacturing Cost Structure Analysis of Prescription Dermatological Drugs in 2021
    Figure 70. Manufacturing Process Analysis of Prescription Dermatological Drugs
    Figure 71. Industry Chain Structure of Prescription Dermatological Drugs
    Figure 72. Channels of Distribution
    Figure 73. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Prescription Dermatological Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Prescription Dermatological Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Prescription Dermatological Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports